BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Palle SK, Naik KB, McCracken CE, Kolachala VL, Romero R, Gupta NA. Racial disparities in presentation and outcomes of paediatric autoimmune hepatitis. Liver Int 2019;39:976-84. [PMID: 30802337 DOI: 10.1111/liv.14081] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Mack CL, Adams D, Assis DN, Kerkar N, Manns MP, Mayo MJ, Vierling JM, Alsawas M, Murad MH, Czaja AJ. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology. 2020;72:671-722. [PMID: 31863477 DOI: 10.1002/hep.31065] [Cited by in Crossref: 104] [Cited by in F6Publishing: 94] [Article Influence: 52.0] [Reference Citation Analysis]
2 Katz M, Gillespie S, Stevens JP, Hall L, Kolachala V, Ford R, Levin K, Gupta NA. African American Pediatric Liver Transplant Recipients Have an Increased Risk of Death After Transferring to Adult Healthcare. J Pediatr 2021;233:119-125.e1. [PMID: 33667506 DOI: 10.1016/j.jpeds.2021.02.069] [Reference Citation Analysis]
3 Duclos-Vallée JC, Debray D, De Martin E, Beux EL, Louvet A. Best practice guidelines for France regarding the diagnosis and management of autoimmune hepatitis. Clin Res Hepatol Gastroenterol 2022;:101871. [PMID: 35108657 DOI: 10.1016/j.clinre.2022.101871] [Reference Citation Analysis]
4 Kemme S, Mack CL. Pediatric Autoimmune Liver Diseases: Autoimmune Hepatitis and Primary Sclerosing Cholangitis. Pediatr Clin North Am 2021;68:1293-307. [PMID: 34736590 DOI: 10.1016/j.pcl.2021.07.006] [Reference Citation Analysis]
5 Lee BT, Tana MM, Kahn JA, Dara L. We Are Not Immune: Racial and Ethnic Disparities in Autoimmune Liver Diseases. Hepatology 2021. [PMID: 34056734 DOI: 10.1002/hep.31985] [Reference Citation Analysis]
6 Zhou Z, Lai P, Zhang S, Wang Y, Qu N, Lu D, Gao L, Xu L, Yang Y, Zhang T, Sun X, Zheng X, Liu Y, Liang H, Chen S. The Relationship between Hepatic Myeloid-Derived Suppressor Cells and Clinicopathological Parameters in Patients with Chronic Liver Disease. Biomed Res Int 2021;2021:6612477. [PMID: 33860040 DOI: 10.1155/2021/6612477] [Reference Citation Analysis]
7 Hadley TA, Palle SK, Venkateswaran S, Abramowsky C, Gillespie S, Hall L, Kolachala VL, Gupta NA. A two decade long study of disease progression of de novo and recurrent autoimmune hepatitis in the pediatric population. Pediatr Transplant 2021;25:e13978. [PMID: 33522659 DOI: 10.1111/petr.13978] [Reference Citation Analysis]
8 Mogahed E, El-Karaksy H, Zaki H, Abdullatif H. Autoimmune hepatitis in Egyptian children: A single center experience. Int J Immunopathol Pharmacol 2022;36:20587384211073265. [PMID: 35231187 DOI: 10.1177/20587384211073265] [Reference Citation Analysis]
9 Stevens JP, Hall L, Gupta NA. TRANSITION of Pediatric Liver Transplant Patients to Adult Care: a Review. Curr Gastroenterol Rep 2021;23:3. [PMID: 33523312 DOI: 10.1007/s11894-020-00802-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Lee JY, Danford CJ, Patwardhan VR, Bonder A. Increased Posttransplant Mortality for Autoimmune Hepatitis Compared With Other Autoimmune Liver Diseases. Journal of Clinical Gastroenterology 2020;54:648-54. [DOI: 10.1097/mcg.0000000000001271] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
11 Hadley T, Gillespie S, Espinoza H, Prince J, Gronbaek H, Chandrakasan S, Kuguthasan S, Kolachala VL, Gupta NA. Soluble PD1 levels are increased with disease activity in paediatric onset autoimmune hepatitis and inflammatory bowel disease. Autoimmunity 2020;53:253-60. [PMID: 32370568 DOI: 10.1080/08916934.2020.1755964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]